April 10, 2019 | Daily JAM, INCY, Volatility, You Might Have Missed |
There's a good chance that Incyte (INCY) will miss Wall Street earnings and revenue projections when it reports first quarter results on April 30. That's because Incyte is a biotech adolescent. Think awkward. The company is old enough to have substantial revenue from...
April 4, 2019 | Daily JAM, NKTR, Stock Alerts |
Nektar Therapeutics (NKTR) won't miss Wall Street earnings projections when it reports its first quarter financial results on May 9--because the company won't report any earnings. The consensus projection now has the company reporting a loss of 76 cents a share on...